Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

PubMed Links for Books (Select 1873774)

1.
2.

Declining access to alcohol and drug abuse services among veterans in the general population.

Tessler R, Rosenheck R, Gamache G.

Mil Med. 2005 Mar;170(3):234-8.

PMID:
15828701
3.

Mental health service delivery and suicide risk: the role of individual patient and facility factors.

Desai RA, Dausey DJ, Rosenheck RA.

Am J Psychiatry. 2005 Feb;162(2):311-8.

PMID:
15677596
4.

A model of consumer-provider partnership: Vet-to-Vet.

Resnick SG, Armstrong M, Sperrazza M, Harkness L, Rosenheck RA.

Psychiatr Rehabil J. 2004 Fall;28(2):185-7.

PMID:
15605756
5.
6.

Measuring quality of pharmacotherapy for depression in a national health care system.

Busch SH, Leslie D, Rosenheck R.

Med Care. 2004 Jun;42(6):532-42.

PMID:
15167321
7.

Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure.

Walter LC, Davidowitz NP, Heineken PA, Covinsky KE.

JAMA. 2004 May 26;291(20):2466-70.

PMID:
15161897
8.

An exploratory analysis of correlates of recovery.

Resnick SG, Rosenheck RA, Lehman AF.

Psychiatr Serv. 2004 May;55(5):540-7.

PMID:
15128962
9.

Change in mental health service delivery among blacks, whites, and Hispanics in the Department of Veterans Affairs.

Greenberg GA, Rosenheck RA.

Adm Policy Ment Health. 2003 Sep;31(1):31-43.

PMID:
14650647
10.
11.

Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.

Rosenheck R, Perlick D, Bingham S, Liu-Mares W, Collins J, Warren S, Leslie D, Allan E, Campbell EC, Caroff S, Corwin J, Davis L, Douyon R, Dunn L, Evans D, Frecska E, Grabowski J, Graeber D, Herz L, Kwon K, Lawson W, Mena F, Sheikh J, Smelson D, Smith-Gamble V; Department of Veterans Affairs Cooperative Study Group on the Cost-Effectiveness of Olanzapine.

JAMA. 2003 Nov 26;290(20):2693-702.

PMID:
14645311
12.

Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs.

Petrakis IL, Leslie D, Rosenheck R.

Alcohol Clin Exp Res. 2003 Nov;27(11):1780-4.

PMID:
14634494
13.

Hospital use and survival among Veterans Affairs beneficiaries.

Ashton CM, Souchek J, Petersen NJ, Menke TJ, Collins TC, Kizer KW, Wright SM, Wray NP.

N Engl J Med. 2003 Oct 23;349(17):1637-46.

14.

Risk adjustment in studies using administrative data.

Sernyak MJ, Rosenheck R.

Schizophr Bull. 2003;29(2):267-71.

15.

Cost-effectiveness of supported housing for homeless persons with mental illness.

Rosenheck R, Kasprow W, Frisman L, Liu-Mares W.

Arch Gen Psychiatry. 2003 Sep;60(9):940-51.

PMID:
12963676
16.

The use of antidepressants in alcohol-dependent veterans.

Petrakis IL, Leslie D, Rosenheck R.

J Clin Psychiatry. 2003 Aug;64(8):865-70.

PMID:
12926999
17.

Fiscal strain and access to opiate substitution therapy at Department of Veterans Affairs Medical Centers.

Rosenheck R, Leslie D, Woody G.

Am J Addict. 2003 May-Jun;12(3):220-8.

PMID:
12851018
18.

Overrepresentation of women veterans among homeless women.

Gamache G, Rosenheck R, Tessler R.

Am J Public Health. 2003 Jul;93(7):1132-6.

19.

Effect of the transformation of the Veterans Affairs Health Care System on the quality of care.

Jha AK, Perlin JB, Kizer KW, Dudley RA.

N Engl J Med. 2003 May 29;348(22):2218-27.

20.

Undiagnosed hyperglycemia in clozapine-treated patients with schizophrenia.

Sernyak MJ, Gulanski B, Leslie DL, Rosenheck R.

J Clin Psychiatry. 2003 May;64(5):605-8.

PMID:
12755666
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk